XM does not provide services to residents of the United States of America.

XM does not provide services to residents of the United States of America.
C
C

Corteva

News

Reuters - 1 day ago

3M, Corteva, Chemours hit with class action over 'forever chemicals' in carpet

3M, Corteva, Chemours hit with class action over 'forever chemicals' in carpet By Brendan Pierson Aug 30 (Reuters) - 3M MMM.N , Corteva CTVA.N and Chemours CC.N were hit with a class action lawsuit on Friday accusing them of covering up the health risks of so-called "forever chemicals" used in carpets and rugs nationwide. The lawsuit , filed in Minnesota federal court, seeks to represent a class of everyone in the United States who bought and installed carpets before 2020 in buildings they own.
C
Reuters - 3 days ago

U.S. Alamo Group, Cognizant, Moderna

U.S. RESEARCH ROUNDUP-Alamo Group, Cognizant, Moderna Aug 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alamo Group, Cognizant and Moderna, on Wednesday. HIGHLIGHTS * Alamo Group Inc ALG.N : D.A. Davidson raises target price to $219 from $209 * Cognizant CTSH.O : Jefferies reinstates coverage with buy rating; price target $90 * Moderna MRNA.O : HSBC raises to hold from reduce * Sonic Automotive SAH.N : CFRA rais
C
C
C
E
Reuters - 4 weeks ago

Bayer earnings hit by tough farm market in fresh challenge for CEO

UPDATE 3-Bayer earnings hit by tough farm market in fresh challenge for CEO Adds details and CEO quote on overhaul from paragraph 6 By Ludwig Burger FRANKFURT, Aug 6 (Reuters) - Bayer BAYGn.DE posted a 16.5% drop in quarterly adjusted earnings on Tuesday, becoming the latest agricultural chemicals supplier to be hit by weak demand due to lower grains prices and adding to the CEO's challenges in his second year in the job.
B
B
C
Reuters - 4 weeks ago

Corteva competitor Inari must face seed patent lawsuit

Corteva competitor Inari must face seed patent lawsuit By Blake Brittain Aug 5 (Reuters) - Agriculture technology giant Corteva Agriscience CTVA.N can move forward with its lawsuit accusing startup Inari Agriculture of unlawfully copying its patented seeds, according to a ruling made public in Delaware federal court on Monday. U.S. District Judge John Murphy refused to dismiss the lawsuit, finding that Inari failed to prove at an early stage of the case that its Belgian subsidiary could develop
D
C
Reuters - 4 weeks ago

Bunge, ADM to benefit as US farmers sell cheap crops in 'haul of shame'

ANALYSIS-Bunge, ADM to benefit as US farmers sell cheap crops in 'haul of shame' By Tom Polansek and P.J. Huffstutter CHICAGO, Aug 5 (Reuters) - A spike in bargain-basement crop sales by U.S. farmers needing to make room in storage bins for autumn harvests could boost profitability at grain handlers such as Archer-Daniels-Midland ADM.N and Bunge Global BG.N .
B
C
Reuters - 4 weeks ago

U.S. Apple, Centerpoint Energy, Cummins

U.S. RESEARCH ROUNDUP-Apple, Centerpoint Energy, Cummins Aug 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Apple, Centerpoint Energy and Cummins, on Friday. HIGHLIGHTS * Apple Inc AAPL.O : Wedbush raises target price to $285 from $275 * Centerpoint Energy CNP.N : JP Morgan cuts to neutral from overweight * Cummins CMI.N : Jefferies raises target price to $365 from $345 * Motorola MSI.N : JP Morgan raises target pr
A
A
B
B
I
K
M
A
B
C
A
A
A
A
C
C
L
M
Reuters - 4 weeks ago

Corteva Inc reports results for the quarter ended in June - Earnings Summary

Corteva Inc reports results for the quarter ended in June - Earnings Summary Corteva Inc CTVA.N reported quarterly adjusted earnings of $1.83​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $1.60. The mean expectation of eighteen analysts for the quarter was for earnings of $1.73 per share.
C
Reuters - 4 weeks ago

Corteva Announces CFO Dave Anderson Retirement

BRIEF-Corteva Announces CFO Dave Anderson Retirement July 31 (Reuters) - Corteva Inc CTVA.N : CORTEVA ANNOUNCES CFO DAVE ANDERSON RETIREMENT, APPOINTS DAVID JOHNSON AS EVP, CHIEF FINANCIAL OFFICER CORTEVA INC - CURRENT CFO DAVE ANDERSON TO RETIRE IN Q1 2025 Source text for Eikon: ID:nPn9XRFl2a Further company coverage: CTVA.N
C
Reuters - 4 weeks ago

Herbicide maker FMC beats profit estimates on uptick in sales volumes

Herbicide maker FMC beats profit estimates on uptick in sales volumes July 31 (Reuters) - Agrichemicals firm FMC FMC.N beat Wall Street estimates for quarterly profit on Wednesday, aided by a revamp to rein in costs and strong sales volumes in key markets U.S. and Brazil. Shares rose 5.6% after the bell. FMC took a slew of actions as part of its restructuring plan last year including layoffs in its Brazil business.
C
F
Reuters - 4 weeks ago

Corteva Reports Second Quarter And First Half 2024 Results

BRIEF-Corteva Reports Second Quarter And First Half 2024 Results July 31 (Reuters) - Corteva Inc CTVA.N : CORTEVA REPORTS SECOND QUARTER AND FIRST HALF 2024 RESULTS, UPDATES FULL-YEAR GUIDANCE QTRLY NET SALES $6,112 MILLION QTRLY EPS $1.51 Q2 EARNINGS PER SHARE VIEW $1.73, REVENUE VIEW $6.16 BILLION -- LSEG IBES DATA QTRLY OPERATING EPS $1.83 Sourc
C
Reuters - 4 weeks ago

Corteva trims 2024 forecasts on pricing pressure in crop protection

UPDATE 2-Corteva trims 2024 forecasts on pricing pressure in crop protection Recasts paragraph 1, adds forecast, details throughout July 31 (Reuters) - Corteva CTVA.N cut its annual sales and operating earnings forecasts on Wednesday as the U.S. agrichemicals maker faces declining prices at its crop protection unit, sending its shares down 5.7% in trading after the bell.
B
B
D
C
Reuters - 4 weeks ago

Corteva beats quarterly profit estimates

Corteva beats quarterly profit estimates July 31 (Reuters) - U.S. agrichemicals firm Corteva CTVA.N beat second-quarter profit estimates on Wednesday, helped by strong prices for its seeds. The Indianapolis-based company reported operating income of $1.83 per share for the three months ended June 30, compared with average analysts' estimate of $1.73 per share, according to LSEG data.
C
Reuters - 4 weeks ago

Corteva Outlook FY Revenue USD 17,200-17,500 Million

BRIEF-Corteva Outlook FY Revenue USD 17,200-17,500 Million Jul 31 (Reuters) - Corteva outlook FY EBITDA growth 4%. outlook FY EPS USD 2.6-2.8 outlook FY EBITDA USD 3,400-3,600 million
C
Reuters - 1 month ago

Corteva Inc <CTVA.N> expected to post earnings of $1.73 a share - Earnings Preview

Corteva Inc expected to post earnings of $1.73 a share - Earnings Preview Corteva Inc CTVA.N , CTVA.K is expected to show a rise in quarterly revenue when it reports results on July 31 for the period ending June 30 2024 The Indianapolis Indiana-based company is expected to report a 1.9% increase in revenue to $6.159 billion from $6.05 billion a year ago, according to the mean estimate from 15 analysts, based on LSEG data.
C
Reuters - 1 month ago

KeyBanc sees prices rising in certain markets after Olin declares force majeure

BUZZ-KeyBanc sees prices rising in certain markets after Olin declares force majeure ** Brokerage KeyBanc Capital Markets sees chemicals maker Olin Corp's OLN.N system-wide force majeure for some product and aromatic shipments due to Hurricane Beryl being a positive for certain markets ** Brokerage sees a short-term positive for the U.S. caustic soda, polyvinyl chloride (PVC) and U.S./European methylenediphenyl diisocyanate (MDI) prices ** The effect of outages at OLN will be temporary and price
D
C
Reuters - 2 months ago

U.S. Alimera Sciences, Comtech Telecommunications, Eli Lilly

U.S. RESEARCH ROUNDUP-Alimera Sciences, Comtech Telecommunications, Eli Lilly June 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alimera Sciences, Comtech Telecommunications and Eli Lilly, on Tuesday. HIGHLIGHTS * Alimera Sciences Inc ALIM.O : Craig-Hallum cuts to hold from buy * Comtech Telecommunications Corp CMTL.O : Jefferies raises to hold from underperform * Eli Lilly LLY.N : Truist Securities raises targe
A
A
E
D
U
V
A
B
C
C
C
F
M
Reuters - 2 months ago

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
C
C
D
M
Reuters - 3 months ago

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
U
T
C
C
D
M

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.